You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ALK fusions

Showing 1 - 25 of 454
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Seoul (Brigatinib)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Apr 29, 2022

Lung Cancer, Non Small Cell Lung Cancer Trial in Aurora (Amivantamab 1050mg, Amivantamab 1400mg, Amivantamab (to be determined))

Not yet recruiting
  • Lung Cancer
  • Non Small Cell Lung Cancer
  • Amivantamab 1050mg
  • +2 more
  • Aurora, Colorado
  • +2 more
Apr 25, 2023

Soft Tissue Sarcoma, Advanced Cancer, Metastatic Cancer Trial in France (Blood and tumor samples)

Recruiting
  • Soft Tissue Sarcoma
  • +2 more
  • Blood and tumor samples
  • Clermont-Ferrand, France
  • +9 more
Dec 8, 2021

Cancer, Cancer Metastatic, NTRK Gene Fusion Overexpression Trial in Worldwide (Data collection and quality of life

Recruiting
  • Cancer
  • +15 more
  • Data collection and quality of life questionnaire
  • Graz, Austria
  • +40 more
Jul 27, 2021

Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

Recruiting
  • Breast Cancer
  • +15 more
  • Goodyear, Arizona
  • +146 more
Aug 24, 2022

Solid Tumors, CNS Tumors Trial in Worldwide (Entrectinib)

Recruiting
  • Solid Tumors
  • CNS Tumors
  • Orange, California
  • +38 more
Aug 24, 2022

Tumors, Colorectal Tumors, Melanoma Trial in United States (Alectinib)

Terminated
  • Neoplasms
  • +27 more
  • Culver City, California
  • +28 more
Jul 25, 2022

Either EML4-ALK Gene Rearrangements or T790M EGFR Mutation in

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
    • Hollywood, Florida
    • +1 more
    Sep 29, 2021

    ALK Tyrosine Kinase Inhibitors in ALK-rearranged Advanced Pure

    Completed
    • Non-small Cell Lung Cancer
    • Changsha, Hunan, China
      Hunan Cancer Hospital
    Sep 23, 2021

    Non Small Cell Lung Cancer, CNS Progression Trial in Aurora (Temozolomide plus Osimertinib, Temozolomide plus Lorlatinib)

    Active, not recruiting
    • Non Small Cell Lung Cancer
    • CNS Progression
    • Temozolomide plus Osimertinib
    • Temozolomide plus Lorlatinib
    • Aurora, Colorado
      University of Colorado Hospital
    May 12, 2022

    Locally Advanced Solid Tumors, Metastatic Solid Tumors, Lymphoma Trial in Worldwide (Oral repotrectinib (TPX-0005))

    Recruiting
    • Locally Advanced Solid Tumors
    • +3 more
    • Oral repotrectinib (TPX-0005)
    • Los Angeles, California
    • +27 more
    Aug 9, 2022

    Cancers With NTRK, ROS1, or ALK Gene Fusions Trial in San Diego (Entrectinib)

    No longer available
    • Cancers With NTRK, ROS1, or ALK Gene Fusions
    • San Diego, California
      1-844-Startrk (782-7875)
    Apr 24, 2019

    NSCLC, ALK Gene Rearrangement Positive Trial in France (RNAseq)

    Recruiting
    • Non-small Cell Lung Cancer
    • ALK Gene Rearrangement Positive
    • RNAseq
    • Saint-Denis, La Réunion, France
    • +44 more
    Nov 4, 2021

    NSCLC NSCLC Trial in Worldwide (Durvalumab, Placebo for Olaparib, Olaparib)

    Active, not recruiting
    Has Results
    • Non-small Cell Lung Cancer NSCLC
    • Bonita Springs, Florida
    • +67 more
    Nov 15, 2022

    NSCLC, NSCLC Metastatic, NSCLC Recurrent Trial in Worldwide (Alectinib)

    Terminated
    • Non-small Cell Lung Cancer
    • +2 more
    • Brussels, Belgium
    • +18 more
    Aug 23, 2022

    Malignant Solid Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Trial in Puerto

    Recruiting
    • Malignant Solid Neoplasm
    • +26 more
    • Birmingham, Alabama
    • +121 more
    Aug 24, 2022

    Non Small Cell Lung Cancer NSCLC Trial in Worldwide (Durvalumab, Tremelimumab, Abraxane + carboplatin)

    Recruiting
    Has Results
    • Non Small Cell Lung Cancer NSCLC
    • Phoenix, Arizona
    • +181 more
    Aug 17, 2022

    Noninvasive vs. Invasive Lung Evaluation

    Completed
    • Non-Small Cell Lung Cancer
    • Guardant360
    • (no location specified)
    Apr 29, 2021

    Cancer, Adult Solid Tumor, Lymphoma Trial in United States

    Recruiting
    • Cancer
    • +3 more
      • Birmingham, Alabama
      • +39 more
      Sep 28, 2021

      NSCLC Trial (QL1706 injection, Vinorelbine Tartrate, Paclitaxel)

      Not yet recruiting
      • Carcinoma, Non-Small-Cell Lung
      • QL1706 injection
      • +6 more
      • (no location specified)
      Aug 3, 2022

      LIQUIK: LIQUId Biopsy for Detection of Actionable Genomic

      Recruiting
      • Non Small Cell Lung Cancer
        • Los Angeles, California
        • +5 more
        Jun 9, 2022

        Genotyping of Ebus-tbna Supernant Cell-free Dna in Nsclc

        Unknown status
        • Lung Cancer
        • Molecular analysis of surnatant
        • Toulouse, France
          Nicolas Guibert
        Nov 9, 2020

        Concordance of Key Actionable Genomic Alterations as Assessed in

        Terminated
        Has Results
        • Non Small Cell Lung Carcinoma
          • Torrance, California
          • +21 more
          Nov 9, 2020

          NSCLC (NSCLC) Trial (MK-2870, Docetaxel, Pemetrexed)

          Not yet recruiting
          • Non-small Cell Lung Cancer (NSCLC)
          • MK-2870
          • +2 more
          • (no location specified)
          Oct 3, 2023

          Solid Tumor Trial (TL118 Capsule)

          Not yet recruiting
          • Solid Tumor
          • TL118 Capsule
          • (no location specified)
          Aug 18, 2023